Jeromie Ballreich

1.0k total citations
56 papers, 654 citations indexed

About

Jeromie Ballreich is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Jeromie Ballreich has authored 56 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Economics and Econometrics, 11 papers in Public Health, Environmental and Occupational Health and 7 papers in General Health Professions. Recurrent topics in Jeromie Ballreich's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (15 papers) and Healthcare Policy and Management (6 papers). Jeromie Ballreich is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (15 papers) and Healthcare Policy and Management (6 papers). Jeromie Ballreich collaborates with scholars based in United States, Canada and Australia. Jeromie Ballreich's co-authors include G. Caleb Alexander, Gerard F. Anderson, Karen Davis, Jonothan C. Tierce, Irene B. Murimi, James Heyward, David A. Thomas, Grant Baldwin, Wilson M. Compton and Christopher M. Jones and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jeromie Ballreich

47 papers receiving 639 citations

Peers

Jeromie Ballreich
Raafat Seifeldin United States
Liyang Yu United States
Elvan Daniels United States
Susan Spillane United States
J. Gourmelen France
Debbie L. Wilson United States
Deneen Vojta United States
Ian Schmid United States
Indah Suci Widyahening Indonesia
Atefeh Noori Iran
Raafat Seifeldin United States
Jeromie Ballreich
Citations per year, relative to Jeromie Ballreich Jeromie Ballreich (= 1×) peers Raafat Seifeldin

Countries citing papers authored by Jeromie Ballreich

Since Specialization
Citations

This map shows the geographic impact of Jeromie Ballreich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeromie Ballreich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeromie Ballreich more than expected).

Fields of papers citing papers by Jeromie Ballreich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeromie Ballreich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeromie Ballreich. The network helps show where Jeromie Ballreich may publish in the future.

Co-authorship network of co-authors of Jeromie Ballreich

This figure shows the co-authorship network connecting the top 25 collaborators of Jeromie Ballreich. A scholar is included among the top collaborators of Jeromie Ballreich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeromie Ballreich. Jeromie Ballreich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Socal, Mariana P., et al.. (2025). US Antibiotic Importation and Supply Chain Vulnerabilities. JAMA Health Forum. 6(10). e253871–e253871.
2.
Young, Daniel L., Erik H. Hoyer, Jeromie Ballreich, Ximin Li, & Elizabeth Colantuoni. (2025). Daily Physical Therapy in the Hospital Reduces Need for Post-acute Care. Archives of Physical Medicine and Rehabilitation. 106(4). e34–e34.
3.
Alexander, G. Caleb, Jill Curran, Hemalkumar B. Mehta, et al.. (2025). US Public Health Gains from Improved Treatment of Hypercholesterolemia: A Simulation Study of NHANES Adults Treated to Guideline-Directed Therapy. Journal of General Internal Medicine. 1 indexed citations
4.
Ballreich, Jeromie, et al.. (2024). Medicaid spending and utilization of gene and RNA therapies for rare inherited conditions. Health Affairs Scholar. 2(5). qxae051–qxae051. 2 indexed citations
5.
Abusamaan, Mohammed S., Jeromie Ballreich, Adrian S. Dobs, et al.. (2024). Effectiveness of artificial intelligence vs. human coaching in diabetes prevention: a study protocol for a randomized controlled trial. Trials. 25(1). 325–325. 2 indexed citations
6.
Ballreich, Jeromie, et al.. (2024). Biopharmaceutical pipeline funded by venture capital firms, 2014 to 2024. Health Affairs Scholar. 2(10). qxae124–qxae124. 3 indexed citations
7.
8.
Ballreich, Jeromie, et al.. (2024). Clinical Evidence Supporting FDA Approval of Gene and RNA Therapies for Rare Inherited Conditions. Pediatric Drugs. 26(6). 741–752. 3 indexed citations
9.
Jung, Yong Wook, et al.. (2024). COST EFFECTIVENESS ANALYSIS OF IMPLEMENTING A SCREENING PROGRAM FOR EARLY-STAGE ALZHEIMER’S DISEASE DETECTION. Innovation in Aging. 8(Supplement_1). 958–959.
10.
Colantuoni, Elizabeth, et al.. (2023). Impaired hospitalized patient mobility is associated with nurse injuries. Occupational Medicine. 73(9). 554–556. 3 indexed citations
11.
12.
Reitsma, Marissa B, Stacie B. Dusetzina, Jeromie Ballreich, Antonio J. Trujillo, & Michelle M. Mello. (2023). Examining Opportunities to Increase Savings From Medicare Price Negotiations. JAMA Internal Medicine. 183(6). 581–581. 6 indexed citations
13.
Ballreich, Jeromie, et al.. (2023). Accelerated approval drug labels often lack information for clinical decision‐making. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(4). 300–304. 2 indexed citations
14.
Trujillo, Antonio J., et al.. (2022). Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?. Health Economics Review. 12(1). 37–37. 1 indexed citations
15.
Patenaude, Bryan & Jeromie Ballreich. (2022). Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19. BMC Public Health. 22(1). 1792–1792. 6 indexed citations
16.
17.
Levin, Jonathan, Jeromie Ballreich, Mariana P. Socal, Ge Bai, & Geoffrey M. Anderson. (2019). PNS110 CONSOLIDATED DRUG PURCHASING ACROSS FEDERAL AGENCIES: A SOLUTION TO IMPROVE DRUG AFFORDABILITY IN MEDICARE PART D. Value in Health. 22. S303–S303. 1 indexed citations
18.
Compton, Wilson M., James Heyward, Jan L. Losby, et al.. (2018). Prescription Drug Coverage for Treatment of Low Back Pain Among U.S. Medicaid, Medicare Advantage and Commercial Insurers. Value in Health. 21. S258–S259. 1 indexed citations
19.
Padula, William V., Jeromie Ballreich, & Gerard F. Anderson. (2018). Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry. Applied Health Economics and Health Policy. 16(6). 753–763. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raafat Seifeldin Breakdown of academic impact, for papers by Liyang Yu Breakdown of academic impact, for papers by Elvan Daniels Breakdown of academic impact, for papers by Susan Spillane Breakdown of academic impact, for papers by J. Gourmelen Breakdown of academic impact, for papers by Debbie L. Wilson Breakdown of academic impact, for papers by Deneen Vojta Breakdown of academic impact, for papers by Ian Schmid Breakdown of academic impact, for papers by Indah Suci Widyahening Breakdown of academic impact, for papers by Atefeh Noori
Rankless by CCL
2026